COVID-19 and Acute Kidney Injury ― Direct and Indirect Pathophysiological Mechanisms Underlying Lesion Development

Autor: ANTÔNIO V.B. DA SILVA, JOÃO DE A.G. CAMPANATI, ISADORA DE S. BARCELOS, ALBERTO C.L. SANTOS, UILDSON P. DE DEUS, TELMA DE J. SOARES, LILIANY S. DE B. AMARAL
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Anais da Academia Brasileira de Ciências, Vol 94, Iss suppl 3 (2022)
Druh dokumentu: article
ISSN: 1678-2690
0001-3765
17994810
DOI: 10.1590/0001-3765202220211501
Popis: Abstract COVID-19 is a pandemic disease caused by the SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) responsible for millions of deaths worldwide. Although the respiratory system is the main target of COVID-19, the disease can affect other organs, including the kidneys. Acute Kidney Injury (AKI), commonly seen in patients infected with COVID-19, has a multifactorial cause. Several studies associate this injury with the direct involvement of the virus in renal cells and the indirect damage stimulated by the infection. The direct cytopathic effects of SARS-CoV-2 are due to the entry and replication of the virus in renal cells, changing several regulatory pathways, especially the renin-angiotensin-aldosterone system (RAAS), with repercussions on the kallikrein-kinin system (KKS). Furthermore, the virus can deregulate the immune system, leading to an exaggerated response of inflammatory cells, characterizing the state of hypercytokinemia. The such exaggerated inflammatory response is commonly associated with hemodynamic changes, reduced renal perfusion, tissue hypoxia, generation of reactive oxygen species (ROS), endothelial damage, and coagulopathies, which can result in severe damage to the renal parenchyma. Thereby, understanding the molecular mechanisms and pathophysiology of kidney injuries induced by SARS-COV-2 is of fundamental importance to obtaining new therapeutic insights for the prevention and management of AKI.
Databáze: Directory of Open Access Journals
Externí odkaz: